secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001549084-22-000069
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics Q3 revenue up 9.2% to $3.3M; net loss widens to $4.3M; record 33 EksoNR bookings
--------------------------------------------------------------------------------

- Revenue $3.3M (+9.2% YoY); nine-month revenue $9.4M (+30.6% YoY).
- Record bookings of 33 EksoNR units in Q3; driven by increase in international orders.
- Gross margin fell to 51% in Q3 from 59% a year ago due to higher service and supply chain costs.
- Net loss applicable to common stockholders $4.3M ($0.33 per share) vs $2.0M ($0.15) in Q3 2021.
- Cash position $29.2M at Sept 30, 2022, down from $40.4M at Dec 31, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000069/0001549084-22-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000069/ekso-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001549084-22-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer